RxDoctor Payments Data

Nirav Amin, MD

Orthopaedic Surgery · Placentia, CANPI 1477714665

Payments from drug & device makers

What this record shows

This record is dominated by other: $3,836,783 of the $5,612,402 with a category attached, or 68.4%. Linvatec Corporation accounts for 66.1% of it on its own, with 59 other manufacturers making up the rest. Reporting peaked in 2022 at $2,277,817 and has fallen 55.8% since, to $1,006,545 in 2025. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,612,402in general payments, 2019–2025

Across 1,877 payments — averaging $2990.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$3.7M
  • Zimmer Biomet$483K
  • Smith+Nephew$450K
  • Pacira Pharmaceuticals Incorporated$347K
  • Trice Medical, Inc.$177K
  • Medical Device Business Services, Inc.$97K
  • plus $348K from 54 others
$59,302in research payments, 2019–2025

Across 16 payments — averaging $3706.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$50K
  • Anika Therapeutics, Inc.$5K
  • Zimmer Biomet$4K
$150,166in ownership & investment interests, 2019–2025

Across 18 payments — averaging $8342.58 each. An ownership or investment interest held by the physician or an immediate family member.

  • Zimmer Biomet$150K
  • Biorez, Inc.$0
  • Trice Medical, Inc.$0

What the payments were for

  • Royalty or licence$111,1832%
  • Consulting fees$917,18516%
  • Speaking & faculty fees$301,1925%
  • Travel & lodging$206,6004%
  • Food & beverage$46,9601%
  • Education$192,4233%
  • Gifts$770%
  • Other$3,836,78368%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Linvatec Corporation24$3,711,231
Zimmer Biomet490$482,810
Smith+Nephew488$450,275
Pacira Pharmaceuticals Incorporated212$347,001
Trice Medical, Inc.79$176,561
Medical Device Business Services, Inc.85$96,805
Vertex99$84,157
Pacira Therapeutics, Inc.62$68,462
Acelrx Pharmaceuticals, Inc.44$34,514
Innocoll Pharmaceuticals Limited35$32,720
Ossio Inc9$32,216
Baudax Bio Inc.43$30,120
Bioventus LLC40$21,852
Depuy Synthes Products, Inc.4$12,669
US Implant Solutions, LLC26$9,638
Heron Therapeutics, Inc.7$6,903
Bone Support Inc.2$3,165
Abanza Inc.6$1,684
Acumed LLC11$1,399
Pavmed Inc.7$937
Stryker17$822
Johnson & Johnson(2 entities)14$685
KCI USA, Inc.1$600
Miach Orthopaedics, Inc.3$575
Arcuro Medical Inc2$570
Anika Therapeutics, Inc.7$569
Biorez, Inc.1$500
Orpyx Medical Technologies Inc.1$400
Tenex Health Inc.1$288
Myoscience Inc.5$221
Curvafix, Inc.1$197
AbbVie(2 entities)2$144
Davol Inc.2$142
Zurimed Technologies Inc.1$136
Globus Medical3$119
Encore Medical, LP2$111
Vericel Corporation1$101
Electronic Waveform Lab, Inc.3$82
Medtronic2$73
Merz Pharmaceuticals, LLC2$66
Vital Orthopedics LLC1$65
Endeavor Orthopaedics LLC1$63
Redhill Biopharma Inc.4$63
DJO, LLC2$63
Forte Bio-pharma LLC1$62
ERMI LLC1$59
Tersera Therapeutics LLC3$59
IBSA Pharma Inc.3$54
Next Science LLC2$53
Arthrex1$44
Avanos Medical2$35
Saxum Surgical, Inc.1$34
Cartiheal (2009) LTD.1$34
Amgen1$24
Radius Health, Inc.1$23
Merz North America, Inc.1$23
Lucid Diagnostics Inc.1$23
Hikma Pharmaceuticals USA1$22
Eisai Inc.1$19
Scilex Pharmaceuticals Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,612,402 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$255,754
Medicare patients
275
Services billed
2,441

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen52$332
Ibuprofen59$324
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen27$218
Ondansetron Hcl44$176
Oxycodone Hcl23$104
Cephalexin29$89
Ondansetron OdtOndansetron21$74
Meloxicam11$8

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Placentia

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →